
Divalproex
Form: Extended-Release Tablets
Strength: 50 mg, 500 mg
Reference Brands: Depakote ER®(US)
Category: Antipsychotropic Drugs
Divalproex Extended-Release (ER) is a widely prescribed anticonvulsant and mood stabilizer used to treat epilepsy, bipolar disorder, and migraine prophylaxis. This formulation ensures sustained drug release, offering once-daily dosing and improved patient compliance. Marketed in the US under Depakote ER and available across the EU in multiple generic and branded forms, Divalproex ER is manufactured in strengths of 250 mg and 500 mg. Its versatility in neuropsychiatric and neurological conditions makes it a key product for global pharmaceutical sourcing. Ideal for B2B buyers looking to expand in CNS therapeutics, Divalproex ER meets stringent regulatory and quality standards.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Risperidone Long-Acting Injection
Strength: 12.5 mg, 25 mg, 37.5 mg, 50 mg vials/syringes
Form: Long-Acting Injection
Reference Brands: Risperdal Consta(US &EU)
View Details Get EnquiryZuclopenthixol ong-acting IM Injection (Depot)
Strength: 200 mg/mL, 500 mg/mL
Form: Long-acting IM Injection (Depot)
Reference Brands: Clopixol Depot®(US)
View Details Get EnquiryZuclopenthixol Short-acting Intramuscular Injection
Strength: 50 mg/mL
Form: Short-acting Intramuscular Injection
Reference Brands: Clopixol-Acuphase®
View Details Get EnquiryZuclopenthixol tablets
Strength: 10 mg, 25 mg, 40 mg
Form: Oral Tablets
Reference Brands: Clopixol®(EU)
View Details Get Enquiry